The Cigna Group
CI
NYSE
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Net Income | 1.03B | 1.41B | 1.46B | 1.27B | 1.19B |
Total Depreciation and Amortization | -458.00M | 766.00M | 755.00M | 749.00M | -345.00M |
Total Amortization of Deferred Charges | 1.22B | -- | -- | -- | 1.07B |
Total Other Non-Cash Items | 234.00M | -20.00M | -75.00M | -13.00M | -78.00M |
Change in Net Operating Assets | -561.00M | 672.00M | 352.00M | 3.03B | 249.00M |
Cash from Operations | 1.47B | 2.83B | 2.49B | 5.03B | 2.10B |
Capital Expenditure | -365.00M | -403.00M | -397.00M | -408.00M | -345.00M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -4.00M | -443.00M | -- | -- | -- |
Divestitures | 0.00 | -14.00M | 5.00M | 22.00M | -3.00M |
Other Investing Activities | -71.00M | -477.00M | -22.00M | -2.60B | -268.00M |
Cash from Investing | -440.00M | -1.34B | -414.00M | -2.98B | -616.00M |
Total Debt Issued | -286.00M | 1.30B | 183.00M | 1.49B | -- |
Total Debt Repaid | 0.00 | -2.89B | 9.00M | -89.00M | -508.00M |
Issuance of Common Stock | 74.00M | 54.00M | 29.00M | 30.00M | 72.00M |
Repurchase of Common Stock | -544.00M | -624.00M | -154.00M | -962.00M | -1.73B |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -358.00M | -362.00M | -362.00M | -368.00M | -334.00M |
Other Financing Activities | -136.00M | -54.00M | -140.00M | -139.00M | -133.00M |
Cash from Financing | -1.25B | -2.57B | -435.00M | -37.00M | -2.64B |
Foreign Exchange rate Adjustments | 14.00M | -7.00M | 4.00M | 5.00M | 12.00M |
Miscellaneous Cash Flow Adjustments | -467.00M | -- | -- | -- | -- |
Net Change in Cash | -676.00M | -1.09B | 1.65B | 2.01B | -1.14B |